Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
CLPT

CLPT - ClearPoint Neuro Inc Stock Price, Fair Value and News

$13.46-0.93 (-6.46%)
Market Closed

10/100

CLPT

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

10/100

CLPT

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$12.54

Target 3M

$14.11

Target 6M

$13.33

CLPT Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

CLPT Price Action

Last 7 days

-3.9%

Last 30 days

-1.4%

Last 90 days

-43.2%

Trailing 12 Months

-25.0%

CLPT RSI Chart

CLPT Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

CLPT Valuation

Market Cap

382.6M

Price/Earnings (Trailing)

-16.53

Price/Sales (Trailing)

11.14

EV/EBITDA

-16.9

Price/Free Cashflow

-27.66

CLPT Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$12.54

Target 3M

$14.11

Target 6M

$13.33

CLPT Fundamentals

CLPT Revenue

Revenue (TTM)

34.3M

Rev. Growth (Yr)

9.1%

Rev. Growth (Qtr)

-3.84%

CLPT Earnings

Earnings (TTM)

-23.1M

Earnings Growth (Yr)

-18.44%

Earnings Growth (Qtr)

-0.93%

CLPT Profitability

Operating Margin

61.31%

EBT Margin

-66.01%

Return on Equity

-145.77%

Return on Assets

-38.34%

Free Cashflow Yield

-3.61%

CLPT Investor Care

Shares Dilution (1Y)

3.04%

Diluted EPS (TTM)

-0.84

CLPT Alerts

  • 1 major insider sales recently.

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202532.2M33.6M34.3M0
202426.2M28.1M30.4M31.4M
202321.0M21.7M22.3M24.0M
202217.3M19.1M19.7M20.6M
202113.7M14.7M15.7M16.3M
202011.9M11.7M12.3M12.8M
20198.2M9.2M10.3M11.2M
20187.0M6.7M6.8M7.4M
20176.4M7.2M7.3M7.4M
20163.7M4.4M5.1M5.7M
20152.8M1.7M2.3M3.0M
20143.5M4.1M3.8M2.6M
20135.3M4.8M4.6M3.9M
20124.0M4.4M4.4M5.1M
20113.0M3.2M3.5M3.8M
20100002.7M
Get all data in R, Python etc through our Historical Stock Data APIs

About ClearPoint Neuro Inc

CLPT
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain stimulation electrodes and biopsy needles, and the infusion of pharmaceuticals and laser catheters into the brain. It has license and collaboration agreements with Clinical Laserthermia Systems AB, Koninklijke Philips N.V., Blackrock Neurotech, and University of California and San Francisco. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.
 CEO
 WEBSITEclearpointneuro.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES108

ClearPoint Neuro Inc Frequently Asked Questions

CLPT is the stock ticker symbol of ClearPoint Neuro Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of ClearPoint Neuro Inc is 382.58 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check CLPT's fair value in chart for subscribers.

The fair value guage provides a quick view whether CLPT is over valued or under valued. Whether ClearPoint Neuro Inc is cheap or expensive depends on the assumptions which impact ClearPoint Neuro Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CLPT.

As of Wed Jan 28 2026, CLPT's PE ratio (Price to Earnings) is -16.53 and Price to Sales (PS) ratio is 11.14. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CLPT PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, ClearPoint Neuro Inc has provided -0.015 (multiply by 100 for percentage) rate of return.